4.24
price up icon2.42%   0.10
 
loading

Finanzdaten der Maxcyte Inc-Aktie (MXCT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
27.59%
11.34
15.66 8.0045 9.0426 8.5763
Cost Of Revenue
10.81%
1.403
1.5731 0.7934 1.3757 0.9998
Gross Profit
29.47%
9.939
14.09 7.2111 7.6669 7.5765
Operating Expenses
0.12%
22.21
22.19 21.16 20.74 20.75
Benefits Costs and Expenses
0.36%
20.87
20.94 - - 19.46
Costs And Expenses
0.36%
20.87
20.94 21.96 22.12 19.46
Depreciation and Amortization
0.48%
1.068
1.0629 1.0325 0.9774 0.9122
Operating Income/Loss
51.62%
-12.28
-8.0957 -13.95 -13.07 -13.18
Income/Loss From Continuing Operations Before Tax
80.49%
-9.526
-5.2778 8.0045 -10.51 -10.88
Income/Loss From Continuing Operations After Tax
80.49%
-9.526
-5.2778 -11.25 -10.51 -10.88
Net Income/Loss
80.49%
-9.526
-5.2778 -11.25 -10.51 -10.88
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
70,949%
104.09
0.1465 103.45 103.06 102.85
Basic Earnings Per Share
80.00%
-0.09
-0.05 -0.11 -0.10 -0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
medical_devices STE
$207.49
price up icon 1.54%
medical_devices ZBH
$107.12
price up icon 1.24%
medical_devices PHG
$25.11
price up icon 0.32%
$80.04
price up icon 5.57%
$78.91
price up icon 1.91%
medical_devices EW
$74.81
price up icon 1.19%
Kapitalisierung:     |  Volumen (24h):